SpectraScience Inc. announced that it has received regulatory approval for the WavSTAT4 Optical Biopsy System in Saudi Arabia. This approval will result in the delivery of a Marketing Authorization license, which is the first step in selling the technology to hospitals and physicians in the Kingdom of Saudi Arabia.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.97K | |
+3.77% | 210B | |
+8.83% | 186B | |
+31.94% | 158B | |
+33.19% | 113B | |
+5.25% | 66.13B | |
+22.41% | 56.25B | |
+1.34% | 49B | |
-5.92% | 38.16B | |
+1.94% | 35.98B |
- Stock Market
- Equities
- SCIE Stock
- News SpectraScience, Inc.
- SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4